We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
+7.2%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$3.86B
AUM Growth
+$1.56B
Cap. Flow
+$1.56B
Cap. Flow %
40.55%
Top 10 Hldgs %
59.92%
Holding
107
New
12
Increased
23
Reduced
24
Closed
36

Top Buys

Rank Stock Value
1
STNG icon
Scorpio Tankers
STNG
+$132M
2
CCJ icon
Cameco
CCJ
+$117M
3
VST icon
Vistra
VST
+$57M
4
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$46.5M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$44.5M

Top Sells

Rank Stock Value
1
NFE icon
New Fortress Energy
NFE
+$71.4M
2
WSC icon
WillScot Mobile Mini Holdings
WSC
+$56.1M
3
NE icon
Noble Corp
NE
+$52M
4
VAL icon
Valaris
VAL
+$41.1M
5
DEN
Denbury Inc.
DEN
+$34.3M

Sector Composition

Rank Sector Weight
1 Healthcare 16.36%
2 Energy 12.76%
3 Industrials 9.71%
4 Financials 6.9%
5 Technology 4.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KOP icon
26
Koppers
KOP
$850M
$38.9M 1.01%
1,110,997
-22,843
-2% -$759K
PTVE
27
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$38.5M 1%
4,815,783
+363,422
+8% +$3.74M
ARQT icon
28
Arcutis Biotherapeutics
ARQT
$3.3B
$38.5M 1%
3,500,000
+757,481
+28% +$11M
CTIC
29
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$37.6M 0.98%
+8,963,256
New +$46.5M
HOLI
30
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$34.3M 0.89%
1,976,609
-23,391
-1% -$421K
OFIX icon
31
Orthofix Medical
OFIX
$427M
$34.2M 0.89%
+2,043,714
New +$40M
KNSA icon
32
Kiniksa Pharmaceuticals
KNSA
$6.09B
$29.9M 0.77%
2,775,636
+1,206,133
+77% +$15.9M
CMPR icon
33
Cimpress
CMPR
$2.39B
$29.1M 0.76%
664,475
+405,019
+156% +$13.8M
SDGR icon
34
Schrodinger
SDGR
$1.4B
$28.6M 0.74%
1,087,793
+87,793
+9% +$2.09M
LAUR icon
35
Laureate Education
LAUR
$5.06B
$28.1M 0.73%
2,393,482
+1,738,000
+265% +$19.1M
ZYME icon
36
Zymeworks
ZYME
$1.77B
$25.8M 0.67%
2,854,732
-163,485
-5% -$1.43M
ANIP icon
37
ANI Pharmaceuticals
ANIP
$1.71B
$25.7M 0.67%
648,041
+271,909
+72% +$11.5M
DMRC icon
38
Digimarc Corp
DMRC
$168M
$23.7M 0.61%
1,205,718
-8,875
-0.7% -$179K
IDCC icon
39
InterDigital
IDCC
$9.06B
$22.9M 0.59%
314,018
+9,758
+3% +$679K
SPRY icon
40
ARS Pharmaceuticals
SPRY
$601M
$22.7M 0.59%
3,480,712
+490,148
+16% +$3.77M
OUT icon
41
Outfront Media
OUT
$5.29B
$21.7M 0.56%
+1,356,658
New +$23.8M
CCO icon
42
Clear Channel Outdoor Holdings
CCO
$1.23B
$20.9M 0.54%
17,391,427
– –
STRO icon
43
Sutro Biopharma
STRO
$349M
$20.1M 0.52%
436,049
+114,862
+36% +$7.29M
PNT
44
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$19.2M 0.5%
2,645,336
+818,032
+45% +$6.07M
OVID icon
45
Ovid Therapeutics
OVID
$489M
$18.1M 0.47%
7,001,124
+173,059
+3% +$410K
HRTX icon
46
Heron Therapeutics
HRTX
$65.3M
$17.7M 0.46%
11,750,000
– –
KPTI icon
47
Karyopharm Therapeutics
KPTI
$46.2M
$17.3M 0.45%
296,070
-256,905
-46% -$12.7M
KDNY
48
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$16.7M 0.43%
719,809
– –
MX icon
49
Magnachip Semiconductor
MX
$142M
$15.6M 0.41%
1,683,462
-266,638
-14% -$2.64M
HRT
50
DELISTED
HireRight Holdings Corporation
HRT
$15.3M 0.4%
1,440,037
-83,229
-5% -$937K
1
2
3 4 5

Similar funds

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
LAMI
Longview Asset Management (Illinois) Chicago, Illinois $9.56B AUM 25.94% 1-Year Est. Return

Rubric Capital Management (New York)'s Q1 2023 Portfolio in Review

As of Q1 2023, Rubric Capital Management (New York) held 107 positions worth $3.86B, up 68% from $2.29B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Rubric Capital Management (New York) deployed $1.56B of net new capital in Q1 2023, opening 12 new positions and adding to 23 existing holdings. Its largest new stake was Scorpio Tankers: 2,404,567 shares worth $135M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 27% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was Noble Corp, an estimated $52M trimmed.

  • Rubric Capital Management (New York)'s largest Q1 2023 buy was Scorpio Tankers: 2,404,567 shares worth $135M.
  • Rubric Capital Management (New York) added most to Cameco in Q1 2023, an estimated $117M increase.
  • Rubric Capital Management (New York)'s biggest Q1 2023 reduction was Noble Corp, cutting an estimated $52M.
  • Rubric Capital Management (New York) fully exited New Fortress Energy in Q1 2023, selling an estimated $71.4M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 60% of its $3.86B portfolio in Q1 2023.
  • Rubric Capital Management (New York) opened 12 new positions and closed 36 in Q1 2023.
  • Rubric Capital Management (New York)'s portfolio value rose 68% quarter-over-quarter to $3.86B.

Based on Rubric Capital Management (New York)'s 13F filing for Q1 2023, filed 12 May 2023.